-
公开(公告)号:US20240316501A1
公开(公告)日:2024-09-26
申请号:US18680523
申请日:2024-05-31
Inventor: Matthew EISAMAN
IPC: B01D61/44 , B01D61/46 , C02F1/44 , C02F1/461 , C02F1/469 , C02F1/66 , C02F103/06 , C02F103/10
CPC classification number: B01D61/445 , B01D61/46 , C02F1/4618 , C02F1/4693 , C02F1/66 , B01D2311/18 , B01D2313/143 , B01D2313/146 , B01D2317/02 , C02F1/441 , C02F2001/4619 , C02F2103/06 , C02F2103/10 , C02F2201/46115 , C02F2201/46145 , C02F2301/08
Abstract: The disclosure relates to enhancing alkalinity of brine, e.g. seawater, using bipolar membrane electrodialysis (BPMED) without removing divalent cations that otherwise cause scaling. In one embodiment, a BPMED is employed wherein the brine volumetric flow rate through a basification compartment is greater at a given current density than that through a brine compartment which increases the pH of the brine output while keeping it below the precipitation pH. In one embodiment, the spacer located in the basification compartment is thicker than spacers elsewhere in the BPMED so as resist membrane distortion due to the increased hydrostatic pressure in the basification compartment given the greater volumetric flow. The brine output having increased alkalinity can be returned to the ocean to mitigate acidification and enable capture of atmospheric carbon dioxide.
-
公开(公告)号:US11952567B2
公开(公告)日:2024-04-09
申请号:US18201025
申请日:2023-05-23
Applicant: Global Algae Technology, LLC
Inventor: David A. Hazlebeck , William Rickman
IPC: B01D63/02 , B01D61/14 , B01D61/22 , B01D63/04 , B01D65/02 , C12M1/00 , C12M1/26 , C12M1/34 , C12M1/36 , C12N1/02 , C12N1/12
CPC classification number: C12N1/12 , B01D61/146 , B01D61/22 , B01D63/02 , B01D63/04 , B01D63/046 , B01D65/02 , C12M21/02 , C12M29/04 , C12M29/16 , C12M29/18 , C12M29/20 , C12M33/14 , C12M41/32 , C12M41/44 , C12M41/48 , C12M45/00 , C12M47/02 , C12N1/02 , B01D2311/04 , B01D2311/06 , B01D2311/2626 , B01D2311/2688 , B01D2313/18 , B01D2313/26 , B01D2313/50 , B01D2315/06 , B01D2315/08 , B01D2317/02 , B01D2317/022 , B01D2321/04 , B01D2321/18 , B01D2321/185 , B01D2321/40
Abstract: Algae harvesting and cultivating systems and methods for producing high concentrations of algae product with minimal energy. In an embodiment, a dead-end filtration system and method includes at least one tank and a plurality hollow fiber membranes positioned in the at least one tank. An algae medium is pulled through the hollow fiber membranes such that a retentate and a permeate are produced.
-
公开(公告)号:US11938450B1
公开(公告)日:2024-03-26
申请号:US18242922
申请日:2023-09-06
Applicant: Dileep Agnihotri , Masoud Aghajani , Sriram Sambasivam , Joseph John Barelli , Ian Tonner
Inventor: Dileep Agnihotri , Masoud Aghajani , Sriram Sambasivam , Joseph John Barelli , Ian Tonner
CPC classification number: B01D65/109 , B01D61/026 , B01D61/0271 , B01D61/10 , B01D61/12 , B01D63/10 , B01D65/08 , C02F1/441 , C02F1/442 , B01D2317/02 , C02F2103/08 , C02F2209/02 , C02F2209/03 , C02F2209/05 , C02F2209/40 , C02F2301/08 , C02F2303/14 , C02F2303/22
Abstract: A novel reverse osmosis or nanofiltration system (RO/NF) capable of detecting and responding to onset of fouling within the system utilizing uniquely configured membrane permeate flow path within the system which generates a time-sensitive data. Membrane performance data in real-time operating conditions is then utilized for rapid detection of membrane fouling, fouling rate, and cause of fouling, followed by controller-based system generated actions to stop, and recover from fouling or slow-down fouling, and, if required, to predict, plan, and schedule operator intervention steps to recover optimum system operating conditions. The end-result is a novel energy-efficient and fouling-managed advanced (machine learning) reverse osmosis system for brackish water desalination.
-
公开(公告)号:US20240001304A1
公开(公告)日:2024-01-04
申请号:US18037830
申请日:2021-11-22
Applicant: ABEC, Inc.
Inventor: Chris Klopp , Colton Mitchell , Evan Wait
CPC classification number: B01D63/082 , C12M47/12 , B01D2317/02 , B01D2313/18 , B01D2313/243 , B01D2315/10
Abstract: This disclosure generally relates to purification systems using tangential flow filtration (“TFF”) (“TFF systems”) that include at least one single-use, disposable flow path wherein the disposable flow path is comprised of a disposable cassette manifold, disposable tubing (including associated components) and a disposable reactor vessel.
-
公开(公告)号:US11724231B1
公开(公告)日:2023-08-15
申请号:US18100436
申请日:2023-01-23
Applicant: Spot Zero Reverse Osmosis Inc.
Inventor: Benjamin J. Koppenhoefer , Jeffrey Alan Johnson , Jake Zale Dudas , Chad Edward Sullivan Tucker
CPC classification number: B01D61/026 , B01D61/04 , B01D61/08 , C02F1/002 , C02F1/441 , B01D2311/04 , B01D2313/243 , B01D2317/02 , C02F2201/002 , C02F2301/08
Abstract: A reverse osmosis system to be connected to a feed water conduit and producing permeate water is disclosed. The reverse osmosis system includes a plurality of tubular bodies each having a first end and a second end, a first inner end plate attached to the first end of the tubular bodies, and a second inner end plate attached to the second end of the tubular bodies. The plurality of tubular bodies houses a filter, a pump, and two reverse osmosis membranes therein. The plurality of tubular bodies is configured to be connected in in fluid communication with each other via channels disposed within the end plates.
-
6.
公开(公告)号:US20180036684A1
公开(公告)日:2018-02-08
申请号:US15552977
申请日:2015-09-22
Applicant: Dow Global Technologies LLC
Inventor: Steven D. JONS , Jon E. JOHNSON
CPC classification number: B01D61/04 , B01D61/025 , B01D63/12 , B01D2311/04 , B01D2311/2688 , B01D2317/02 , B01D2317/04 , C02F1/441 , C02F1/442 , C02F3/1273 , C02F2103/08 , C02F2201/004 , C02F2201/007 , C02F2203/006 , C02F2209/001 , C02F2209/03 , C02F2301/02 , C02F2303/20 , Y02W10/15
Abstract: A filtration assembly including: i) a hyperfiltration assembly including: a high pressure vessel including a feed port, concentrate port and permeate port, and a plurality of serially arranged spiral wound hyperfiltration membrane modules; ii) a bioreactor assembly including: a plurality of spiral wound bioreactors each comprising a flat sheet having two opposing bio-growth surfaces and a feed spacer spirally wound about an axis (Y); and iii) a fluid flow pathway adapted for fluid connection with a fluid feed source and extending in a parallel flow pattern through the bioreactors, and subsequently into the feed port of the high pressure vessel, successively through the spiral wound hyperfiltration membrane modules in a serial flow pattern and out of the concentrate port and permeate port.
-
公开(公告)号:US09790113B2
公开(公告)日:2017-10-17
申请号:US13822622
申请日:2011-09-14
Applicant: Yoram Cohen , Panagiotis D. Christofides , Anditya Rahardianto , Alex R. Bartman , Aihua Zhu , Han Gu , Larry Xingming Gao
Inventor: Yoram Cohen , Panagiotis D. Christofides , Anditya Rahardianto , Alex R. Bartman , Aihua Zhu , Han Gu , Larry Xingming Gao
IPC: B01D21/30 , C02F9/00 , B01D61/12 , B01D61/22 , B01D61/58 , B01D65/02 , C02F1/44 , B01D61/02 , B01D61/14 , C02F103/08
CPC classification number: C02F9/00 , B01D61/025 , B01D61/12 , B01D61/145 , B01D61/22 , B01D61/58 , B01D65/02 , B01D2311/10 , B01D2311/14 , B01D2311/16 , B01D2311/24 , B01D2317/02 , B01D2317/08 , B01D2321/04 , B01D2321/10 , B01D2321/14 , C02F1/441 , C02F1/444 , C02F2103/08 , C02F2201/007 , C02F2201/008 , C02F2209/005 , C02F2209/03 , C02F2209/40 , Y02A20/131
Abstract: An apparatus includes a filtration skid configured to generate a filtrate through at least one of microfiltration and ultrafiltration. The apparatus further includes a desalination skid fluidly connected to the filtration skid. The desalination skid is configured to perform reverse osmosis desalination on the filtrate to generate a permeate, where the filtrate travels from the filtration skid to the desalination skid without traversing a storage tank. In one embodiment, the apparatus further comprises a controller, where the filtration skid and the desalination skid are integrated to provide self-adaptive operation of the filtration skid and the desalination skid in response to control by at least one of a supervisory controller and a local controller. In one embodiment, the control responds to at least one of temporal variability of feed water quality, a permeate production capacity target, and a permeate quality target.
-
公开(公告)号:US20170246372A1
公开(公告)日:2017-08-31
申请号:US15287065
申请日:2016-10-06
Applicant: CYTONICS CORPORATION
Inventor: Lewis HANNA , John David Laughlin , Shawn Robert Browning
CPC classification number: A61M1/34 , A61K9/0014 , A61K35/16 , A61K35/19 , A61K35/28 , A61K38/1722 , A61K38/1841 , A61K38/19 , A61K38/191 , A61K38/4886 , A61K38/55 , A61L15/32 , A61L15/44 , A61L2300/252 , A61L2300/434 , A61M1/341 , A61M2205/3334 , B01D61/18 , B01D69/02 , B01D69/08 , B01D2313/10 , B01D2313/24 , B01D2317/02 , B01D2317/08 , B01D2325/02 , C07K14/4717 , C07K14/8107 , C12Y304/24 , C12Y304/24023 , C12Y304/24065 , C12Y304/24082 , A61K2300/00
Abstract: Systems and methods for purification and concentration of autologous alpha-2 macroglobulin (A2M) from whole blood and or recombinant A2M are provided. Also provided are methods of treating wounds with A2M. Methods for utilizing A2M in combination with other treatments (e.g., platelets and other growth factors) are provided in addition to combinations with exogenous drugs or carriers. Also provided is a method of producing recombinant A2M wild type or variants thereof where the bait region was modified to enhance the inhibition characteristics of A2M and/or to prolong the half-life of the protein for treating wounds.
-
公开(公告)号:US20170001887A1
公开(公告)日:2017-01-05
申请号:US15187689
申请日:2016-06-20
Applicant: NxStage Medical, Inc.
Inventor: William K. Weigel , Goetz Friederichs , Joseph E. Turk , Jeffrey B. Hover, SR.
CPC classification number: C02F1/4695 , B01D61/42 , B01D61/52 , B01D61/54 , B01D65/02 , B01D2317/02 , B01D2321/04 , B01D2321/12 , C02F1/006 , C02F1/008 , C02F1/32 , C02F1/441 , C02F1/444 , C02F2201/46115 , C02F2201/4613 , C02F2201/46145 , C02F2209/003 , C02F2209/005 , C02F2209/40 , C02F2301/08 , C02F2303/16 , Y10T137/8593
Abstract: A fluid purification system has cells whose purifying capability can be regenerated. Some of the cells are arranged in series to reach a high level of purification. An automatic valve network is controlled to cycle the cells in a way that levels the loads on each, thereby maximizing the service interval for replacing expired cells, enabling all of the cells to be replaced at the same time after having each contributing approximately equally to the purification load, and operated such that at any one time, at least one cell is regenerated so as to enable continuous up-time.
Abstract translation: 流体净化系统具有能够再生净化能力的细胞。 一些细胞串联排列以达到高水平的纯化。 控制自动阀网络以使每个电池的负载平衡的方式循环电池,从而最大化用于替换过期电池的服务间隔,使得所有电池在每次贡献大致相等于之后同时被更换 净化负载,并且操作使得在任何一个时间,再生至少一个电池,以便能够连续正常运行。
-
公开(公告)号:US20160340214A1
公开(公告)日:2016-11-24
申请号:US15214438
申请日:2016-07-19
Applicant: NXSTAGE Medical, Inc.
Inventor: Joseph TURK , William K. WEIGEL , Goetz FRIEDERICHS , Jeffrey B. HOVER, SR.
CPC classification number: C02F1/4695 , B01D61/42 , B01D61/52 , B01D61/54 , B01D65/02 , B01D2317/02 , B01D2321/04 , B01D2321/12 , C02F1/006 , C02F1/008 , C02F1/32 , C02F1/441 , C02F1/444 , C02F2201/46115 , C02F2201/4613 , C02F2201/46145 , C02F2209/003 , C02F2209/005 , C02F2209/40 , C02F2301/08 , C02F2303/16 , Y10T137/8593
Abstract: A fluid purification system has cells whose purifying capability can be regenerated. Some of the cells are arranged in series to reach a high level of purification. An automatic valve network is controlled to cycle the cells in a way that levels the loads on each, thereby maximizing the service interval for replacing expired cells, enabling all of the cells to be replaced at the same time after having each contributing approximately equally to the purification load, and operated such that at any one time, at least one cell is regenerated so as to enable continuous up-time.
-
-
-
-
-
-
-
-
-